Genetic Modifiers of CF: Sibling Study
CF 的遗传修饰:兄弟姐妹研究
基本信息
- 批准号:7589744
- 负责人:
- 金额:$ 78.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAge of OnsetBiologicalCandidate Disease GeneChronicClinicalClinical DataCollectionCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDNADiabetes MellitusDiseaseExocrine pancreatic insufficiencyFamilyFoundationsFunctional disorderGene-ModifiedGenesGeneticGenetic VariationGenotypeGoalsGrowthHeritabilityHeritable Quantitative TraitHuman GenomeLod ScoreLung diseasesMalnutritionMeasuresMedical RecordsMethodsMutationNeurofibromin 2Nutritional statusObstructive Lung DiseasesParentsPatientsPhenotypePrincipal InvestigatorPulmonary function testsRecruitment ActivityRegistriesRespiratory physiologyScanningSeveritiesSeverity of illnessShort Tandem RepeatSiblingsSingle Nucleotide PolymorphismTestingTwin Multiple BirthVariantairway surface liquidcystic fibrosis patientsdensitygenetic linkage analysisgenetic variantlongitudinal analysisnon-geneticpatient registryprospectivetraittransmission process
项目摘要
DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is a highly variable but inevitably fatal disorder caused by mutations in the CFTR gene. The disease manifests as progressive obstructive lung disease due to abnormalities in airway surface liquid and chronic malnutrition due to exocrine pancreatic insufficiency. Survival of CF patients is highly correlated with the severity of lung disease and degree of malnutrition. Although CFTR genotype is predictive of some aspects of the CF phenotype, we are still trying to understand the underlying causes of variation in traits that have significant effect upon survival. To this end, we initiated the CF Twin and Sibling Study to determine the degree to which genetic factors contribute to trait variability independent of CFTR genotype. Analysis of over 600 families with twins or siblings affected with CF reveal that modifier genes underlie variation in lung disease severity, as measured by pulmonary function testing (heritability estimates 0.6-0.8) and malnutrition, as measured by nutritional status (heritability estimates 0.5-0.9). A 10cM short tandem repeat scan of a subset of families has identified several regions of suggestive linkage (LOD scores >2.0) for these traits. Intriguingly, several of the linkage regions for lung function and nutritional status coincide, consistent with the clinical observation of a close relationship between these two quantitative traits. The overall goal of this application is to identify the genes that modify lung function and nutritional status in CF patients. This goal will be achieved by pursuit of the following aims: Aim 1. To confirm and refine regions of linkage for lung function and nutritional status. Aim 2. To identify genetic variants within linkage peaks that contribute to variance in lung function and/or growth in CF patients. Aim 3. To refine estimates of the contribution of genetic and non-genetic factors to variation in CF phenotypes by prospective longitudinal analysis.
描述(由申请人提供):囊性纤维化(CF)是一种高度可变但不可避免的致命性疾病,由 CFTR 基因突变引起。该疾病表现为气道表面液体异常导致的进行性阻塞性肺病和外分泌胰腺功能不全导致的慢性营养不良。 CF患者的生存率与肺部疾病的严重程度和营养不良的程度高度相关。尽管 CFTR 基因型可以预测 CF 表型的某些方面,但我们仍在尝试了解对生存有重大影响的性状变异的根本原因。为此,我们发起了 CF 双胞胎和兄弟姐妹研究,以确定遗传因素对独立于 CFTR 基因型的性状变异的影响程度。对超过 600 个患有 CF 的双胞胎或兄弟姐妹的家庭进行的分析表明,修饰基因是肺部疾病严重程度(通过肺功能测试测量(遗传力估计为 0.6-0.8))和营养不良(通过营养状况测量(遗传力估计为 0.5-0.9)测量)差异的基础。 )。对部分家族的 10cM 短串联重复扫描已识别出这些性状的几个暗示性连锁区域(LOD 分数 >2.0)。有趣的是,肺功能和营养状况的几个连锁区域是一致的,这与这两个数量性状之间密切关系的临床观察结果一致。该应用的总体目标是确定改变 CF 患者肺功能和营养状况的基因。这一目标将通过追求以下目标来实现: 目标 1. 确认和细化肺功能和营养状况的联系区域。目标 2. 鉴定连锁峰内导致 CF 患者肺功能和/或生长差异的遗传变异。目标 3. 通过前瞻性纵向分析完善对遗传和非遗传因素对 CF 表型变异的贡献的估计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Garry R Cutting其他文献
In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis.
在囊性纤维化患者中发现的 655 个 CFTR 变体的体外调节剂反应性。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:5.2
- 作者:
H. Bihler;A. Sivachenko;L. Millen;Priyanka Bhatt;Amita Thakerar Patel;Justin Chin;Violaine Bailey;I. Musisi;André LaPan;Normand E. Allaire;Joshua Conte;Noah R. Simon;Amalia S. Magaret;K. Raraigh;Garry R Cutting;William R. Skach;Robert J. Bridges;Philip J. Thomas;M. Mense - 通讯作者:
M. Mense
Lessons from the CAGI‐4 Hopkins clinical panel challenge
CAGI-4 霍普金斯临床小组挑战的经验教训
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:3.9
- 作者:
J. Chandonia;Aashish N. Adhikari;Marco Carraro;A. Chhibber;Garry R Cutting;Yao Fu;A. Gasparini;David T. Jones;A. Kramer;Kunal Kundu;Hugo Y. K. Lam;E. Leonardi;J. Moult;Lipika R. Pal;D. Searls;Sohela Shah;S. Sunyaev;Silvio C. E. Tosatto;Yizhou Yin;Bethany A Buckley - 通讯作者:
Bethany A Buckley
Two rare variants that affect the same amino acid in CFTR have distinct responses to ivacaftor
影响 CFTR 中相同氨基酸的两种罕见变异对 ivacaftor 有不同的反应
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Hongyu Li;Mayuree Rodrat;Majid K Al;Diana;Sangwoo T Han;K. Raraigh;Garry R Cutting;David N Sheppard - 通讯作者:
David N Sheppard
The clinical utility of sequencing the entirety of CFTR.
对整个 CFTR 进行测序的临床实用性。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:5.2
- 作者:
Molly B Sheridan;M. Aksit;K. Pagel;K. Hetrick;H. Shultz;Ben Myers;K. Buckingham;R. Pace;Hua Ling;Elizabeth Pugh;Wanda K. O’Neal;M J Bamshad;Ronald L. Gibson;M. Knowles;S. Blackman;Garry R Cutting;K. Raraigh - 通讯作者:
K. Raraigh
Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene
变性梯度凝胶电泳技术检测 CFTR 基因已知突变和新型亚洲突变的灵敏度
- DOI:
10.1002/(sici)1098-1004(1997)9:2<136::aid-humu6>3.0.co;2-7 - 发表时间:
1997 - 期刊:
- 影响因子:3.9
- 作者:
M. Macek;B. Mercier;Alice Macková;Patrice W. Miller;A. Hamosh;C. Férec;Garry R Cutting - 通讯作者:
Garry R Cutting
Garry R Cutting的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Garry R Cutting', 18)}}的其他基金
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
囊性纤维化跨膜电导调节器
- 批准号:
7604604 - 财政年份:2006
- 资助金额:
$ 78.65万 - 项目类别:
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
囊性纤维化跨膜电导调节器
- 批准号:
7200823 - 财政年份:2005
- 资助金额:
$ 78.65万 - 项目类别:
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
囊性纤维化跨膜电导调节器
- 批准号:
7378912 - 财政年份:2005
- 资助金额:
$ 78.65万 - 项目类别:
Genetic Modifiers of Cystic Fibrosis: Sibling Study
囊性纤维化的基因修饰:兄弟姐妹研究
- 批准号:
6794626 - 财政年份:2001
- 资助金额:
$ 78.65万 - 项目类别:
Genetic Modifiers of Cystic Fibrosis: Sibling Study
囊性纤维化的基因修饰:兄弟姐妹研究
- 批准号:
6654344 - 财政年份:2001
- 资助金额:
$ 78.65万 - 项目类别:
Genetic Modifiers of Cystic Fibrosis: Sibling Study
囊性纤维化的基因修饰:兄弟姐妹研究
- 批准号:
6527976 - 财政年份:2001
- 资助金额:
$ 78.65万 - 项目类别:
相似国自然基金
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
晶状体mtDNA氧化损伤修复与线粒体自噬的空间差异及其调控干预在年龄相关性白内障发病中的作用
- 批准号:82171038
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
FoxO3a通路抑制在年龄相关性白内障发病机制中的调控作用
- 批准号:82070942
- 批准年份:2020
- 资助金额:57 万元
- 项目类别:面上项目
ODRP泛素化经LECs外泌体释放和自噬降解调控年龄相关性白内障的发病
- 批准号:81974129
- 批准年份:2019
- 资助金额:57 万元
- 项目类别:面上项目
肠道微生态参与年龄相关性黄斑变性的发病机制及固本清目方的干预作用
- 批准号:81973912
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
- 批准号:
10825287 - 财政年份:2024
- 资助金额:
$ 78.65万 - 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
- 批准号:
10668768 - 财政年份:2023
- 资助金额:
$ 78.65万 - 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 78.65万 - 项目类别:
Identifying and understanding the role of repeat RNAs and RAN proteins in Alzheimer's disease
识别和理解重复 RNA 和 RAN 蛋白在阿尔茨海默病中的作用
- 批准号:
10833734 - 财政年份:2023
- 资助金额:
$ 78.65万 - 项目类别:
Characterizing Population Differences between Clinical Trial and Real World Populations
描述临床试验和真实世界人群之间的人群差异
- 批准号:
10703711 - 财政年份:2023
- 资助金额:
$ 78.65万 - 项目类别: